Investigator's Initiated Phase II Study for Pancreatic Cancer Patients

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified December 2013 by Tiltan Pharma Ltd.
Sponsor:
Information provided by (Responsible Party):
Tzivia Berkman, Tiltan Pharma Ltd.
ClinicalTrials.gov Identifier:
NCT01659502
First received: July 23, 2012
Last updated: December 4, 2013
Last verified: December 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is not yet open for participant recruitment.
  Estimated Study Completion Date: No date given
  Estimated Primary Completion Date: October 2014 (Final data collection date for primary outcome measure)